Search: projects

Country:	All Africa    Benin    Botswana    Burkina Faso    Burundi    Cameroon    Cap Vert    Chad    Comores    Congo Brazzaville    Congo RDC    Djibouti    Ethiopia    Gabon    Gambia    Ghana    Guinea    Guinea Bissau    Guinea Conakry    Ivory Coast    Kenya    Lesotho    Liberia    Madagascar    Malawi    Mali    Mauritania    Mauritius    Mozambique    Namibia    Niger    Nigeria    Rwanda    Senegal    Seychelles    Sierra Leone    South Africa    Sudan    Swaziland    Tanzania / Zanzibar    Togo    Uganda    Zambia    ZimbabweAsia    Afghanistan    Armenia    Azerbaijan    Bangladesh    Bhutan    Cambodia    China    India    Indonesia    Kazachstan    Kyrgyzstan    Laos    Moldova    Mongolia    Myanmar    Tajikistan    Thailand    The Philippines    VietnamCaribbean    Antigua and Barbuda    Bahamas    Barbados    Caribbean Partnership    Cuba    Dominica    Dominican Republic    Grenada    Haiti    Jamaica    Montserrat    St. Kitts and Nevis    St. Lucia    St. Vincent and the Grenadines    Trinidad & TobagoEurope    Austria    Belgium    Denmark    France    Germany    Moldova    Montenegro    Romania    Switzerland    The Netherlands    TurkeyGlobal    GlobalLatin America    Belize    Bolivia    Costa Rica    Ecuador    El Salvador    Guatemala    Guyana    Honduras    Nicaragua    Panama    Peru    SurinameMediterranean    Algeria    Egypt    Libya    Morocco    TunisiaMiddle East    Jordan    Palestine    Syria    YemenPacific    East Timor    Papua New Guinea    Solomon Islands
Field of expertise:	All Health Economics and Financing    Cost-effectiveness Studies    Costing Studies    Health Expenditure Review    Health Financing and Provider Payment    Health Insurance    National Health AccountsHealth Programmes    Basic Health Services    HIV-AIDS-STI-TB    Hospital Services    Other Health Programmes    Reproductive HealthHealth System    Health Information System / Epidemiology / Operational Research    Health Policy and Policy Dialogue    Health Sector Reform    Health Sector Review or Health Sector Diagnosis    Monitoring and Evaluation    Planning, Organisation and Management    Public Private Partnership    Sector Wide Approach (SWAp)    Training and Human Resource DevelopmentPharmaceutical Sector    Access to Medicine Campaigns    Drug Pricing Studies    Drug Regulatory Authority Support    Drug Supply Management System Strengthening    Essential Drugs Programme Support    Essential Medicines Financing    Increasing Transparency In Public And Private Pharmaceutical Markets    Medical Store Evaluation    National Medicines Policy Development    Pharmaceutical Sector Review    Procurement and Tender Support    Public Private Partnership Interventions    Quantification of Essential Drug Needs    Rational Use Surveys    Selection of Essential Medicines    Training and Human Resource DevelopmentProject Cycle    Appraisal    Identification and Formulation    Long Term Technical Assistance    Monitoring and Evaluation
Assignment:
Client:
Description:
Order by:	Assignment Client Year Country

---

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat
Country:	Dominica
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat
Country:	Dominican Republic
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	Caricom (Caribbean Community Secretariat)
Country:	Barbados
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	Antigua and Barbuda
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	Grenada
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	Guyana
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	Haiti
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	Jamaica
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	St. Lucia
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	Bahamas
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	Belize
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	Montserrat
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	St. Kitts and Nevis
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	St. Vincent and the Grenadines
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	Trinidad & Tobago
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Regional assessment of Patent and Intellectual Property issues and Access to Medicines
Client:	CARICOM (Caribbean Community Secretariat)
Country:	Suriname
Fields of expertise:	Access to Medicine Campaigns, Appraisal, Drug Regulatory Authority Support, National Medicines Policy Development
Description:	Narrative Description of Project: The general objectives of the Assessment were: To explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework To make recommendations on the IP/patent legislation and regulations that will maximize TRIPS flexibilities while being TRIPS compliant To identify the requirements and process for establishing a regional negotiating platform for drugs To identify mechanisms for building/strengthening coalitions and negotiating positions at the WTO, and in bilateral and regional fora for ensuring access to drugs To make recommendations on the adequacy of the systems in Member States for regulation of the pharmaceutical market to ensure the timely supply of safe, effective and quality medicines. Description of Actual Services Provided: Development of a work plan i consultation with the Technical Advisory Group (TAG) and PANCAP Thorough review of all available literature/documents and prior regional studies pertaining to patent legislation, regulations and decrees that focus, in particular, on TRIPS compliance, TRIPS flexibilities; TRIPS + Provisions, and other general issues relating to patent systems; Data collection, analysis of processes and systems that have been adopted in implementing TRIPS flexibilities, TRIPS+ Provisions, at the practical level in the region and provision of a qualitative assessment of the data collected Recommendations and proposal of strategies for addressing needs and gaps identified at national levels and the establishment of a regional platform for future trade negotiations relating to access to medicines and other pharmaceuticals in the context of the Caribbean Single Market and economy. Development of the data collection instrument Test and modification of the data collation instrument in 2 Member States- one that has a well developed IP system and one with a rudimentary system. Trinidad and Tobago and Guyana; Interviews with the relevant persons and agencies at the country and regional level
Year:	2008 - 2009

Assignment:	Medicines Transparency Alliance (MeTA)
Client:	DFID
Country:	Jordan
Fields of expertise:	Access to Medicine Campaigns, Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Increasing Transparency In Public And Private Pharmaceutical Markets, National Medicines Policy Development, Procurement and Tender Support, Public Private Partnership Interventions, Training and Human Resource Development
Description:	Narrative description of Project: MeTA is a new multi-stakeholder approach for increasing transparency around the selection, procurement, sale and distribution of medicines in Low Income Countries, thereby strengthening governance and encouraging responsible business practices. The MeTA goal is to ensure access to affordable essential drugs in developing countries (MDG 8, target 17). The initiative us being supported financially by DFID during its present Phase One. MeTA brings together, at both the international and national levels, a diverse group of people with an interest in the pharmaceutical sector (stakeholders) to find ways to improve information flows, and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. By doing so, MeTA will improve how decisions are made about medicines, improve the way they are purchased and supplied, encourage innovative and responsible business practices, and increase the voice of patients and consumers. Description of actual services provided by your staff within the assignment: The MeTA International Secretariat is tasked to help to support the implementation of MeTA in 7 pilot countries, through facilitating support for the evolution and effective functioning of the National Secretariats, National Multi-Stakeholder Group (NMSGs), and implementation of work plans. Following the establishment of country MeTA structures, the International MeTA Secretariat provides further support to the pilot countries including: Supporting countries to extract and collate data on medicine quality, availability and pricing along the supply chain; Supporting countries to undertake studies assessing the level of transparency and good governance in medicines regulation and procurement; Working with countries to produce country-specific MeTA reports, which would collate data and further analyse and contextualise issues related to medicine quality, availability and price, and to disseminate these reports through the media and public interest groups; as well as exploring policy options and support needed for implementation e.g. of report recommendations. Assist countries in using the data collated through MeTA on medicine policies and regulation as well as quality, availability and prices to try to promote relevant good practice and policy changes to improve access to medicines. HERA contracted staff are responsible for the provision of country specific support under META. Pilot countries are: Ghana, Uganda, Zambia, the Philippines, Jordan, Kyrgyzstan and Peru.
Year:	2008 - 2010

Assignment:	Medicines Transparency Alliance (MeTA)
Client:	DFID
Country:	Ghana
Fields of expertise:	Access to Medicine Campaigns, Drug Pricing Studies, Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Essential Medicines Financing, Increasing Transparency In Public And Private Pharmaceutical Markets, National Medicines Policy Development, Procurement and Tender Support, Public Private Partnership Interventions, Rational Use Surveys, Training and Human Resource Development
Description:	Narrative description of Project: MeTA is a new multi-stakeholder approach for increasing transparency around the selection, procurement, sale and distribution of medicines in Low Income Countries, thereby strengthening governance and encouraging responsible business practices. The MeTA goal is to ensure access to affordable essential drugs in developing countries (MDG 8, target 17). The initiative us being supported financially by DFID during its present Phase One. MeTA brings together, at both the international and national levels, a diverse group of people with an interest in the pharmaceutical sector (stakeholders) to find ways to improve information flows, and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. By doing so, MeTA will improve how decisions are made about medicines, improve the way they are purchased and supplied, encourage innovative and responsible business practices, and increase the voice of patients and consumers. Description of actual services provided by your staff within the assignment: The MeTA International Secretariat is tasked to help to support the implementation of MeTA in 7 pilot countries, through facilitating support for the evolution and effective functioning of the National Secretariats, National Multi-Stakeholder Group (NMSGs), and implementation of work plans. Following the establishment of country MeTA structures, the International MeTA Secretariat provides further support to the pilot countries including: Supporting countries to extract and collate data on medicine quality, availability and pricing along the supply chain; Supporting countries to undertake studies assessing the level of transparency and good governance in medicines regulation and procurement; Working with countries to produce country-specific MeTA reports, which would collate data and further analyse and contextualise issues related to medicine quality, availability and price, and to disseminate these reports through the media and public interest groups; as well as exploring policy options and support needed for implementation e.g. of report recommendations. Assist countries in using the data collated through MeTA on medicine policies and regulation as well as quality, availability and prices to try to promote relevant good practice and policy changes to improve access to medicines. HERA contracted staff are responsible for the provision of country specific support under META. Pilot countries are: Ghana, Uganda, Zambia, the Philippines, Jordan, Kyrgyzstan and Peru.
Year:	2008 - 2010

Assignment:	Medicines Transparency Alliance (MeTA)
Client:	DFID
Country:	Kyrgyzstan
Fields of expertise:	Access to Medicine Campaigns, Drug Pricing Studies, Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Essential Medicines Financing, Increasing Transparency In Public And Private Pharmaceutical Markets, National Medicines Policy Development, Public Private Partnership Interventions, Rational Use Surveys, Training and Human Resource Development
Description:	Narrative description of Project: MeTA is a new multi-stakeholder approach for increasing transparency around the selection, procurement, sale and distribution of medicines in Low Income Countries, thereby strengthening governance and encouraging responsible business practices. The MeTA goal is to ensure access to affordable essential drugs in developing countries (MDG 8, target 17). The initiative us being supported financially by DFID during its present Phase One. MeTA brings together, at both the international and national levels, a diverse group of people with an interest in the pharmaceutical sector (stakeholders) to find ways to improve information flows, and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. By doing so, MeTA will improve how decisions are made about medicines, improve the way they are purchased and supplied, encourage innovative and responsible business practices, and increase the voice of patients and consumers. Description of actual services provided by your staff within the assignment: The MeTA International Secretariat is tasked to help to support the implementation of MeTA in 7 pilot countries, through facilitating support for the evolution and effective functioning of the National Secretariats, National Multi-Stakeholder Group (NMSGs), and implementation of work plans. Following the establishment of country MeTA structures, the International MeTA Secretariat provides further support to the pilot countries including: Supporting countries to extract and collate data on medicine quality, availability and pricing along the supply chain; Supporting countries to undertake studies assessing the level of transparency and good governance in medicines regulation and procurement; Working with countries to produce country-specific MeTA reports, which would collate data and further analyse and contextualise issues related to medicine quality, availability and price, and to disseminate these reports through the media and public interest groups; as well as exploring policy options and support needed for implementation e.g. of report recommendations. Assist countries in using the data collated through MeTA on medicine policies and regulation as well as quality, availability and prices to try to promote relevant good practice and policy changes to improve access to medicines. HERA contracted staff are responsible for the provision of country specific support under META. Pilot countries are: Ghana, Uganda, Zambia, the Philippines, Jordan, Kyrgyzstan and Peru.
Year:	2008 - 2010

Assignment:	Medicines Transparency Alliance (MeTA)
Client:	DFID
Country:	Peru
Fields of expertise:	Access to Medicine Campaigns, Drug Pricing Studies, Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Essential Medicines Financing, Increasing Transparency In Public And Private Pharmaceutical Markets, National Medicines Policy Development, Public Private Partnership Interventions, Rational Use Surveys, Training and Human Resource Development
Description:	Narrative description of Project: MeTA is a new multi-stakeholder approach for increasing transparency around the selection, procurement, sale and distribution of medicines in Low Income Countries, thereby strengthening governance and encouraging responsible business practices. The MeTA goal is to ensure access to affordable essential drugs in developing countries (MDG 8, target 17). The initiative us being supported financially by DFID during its present Phase One. MeTA brings together, at both the international and national levels, a diverse group of people with an interest in the pharmaceutical sector (stakeholders) to find ways to improve information flows, and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. By doing so, MeTA will improve how decisions are made about medicines, improve the way they are purchased and supplied, encourage innovative and responsible business practices, and increase the voice of patients and consumers. Description of actual services provided by your staff within the assignment: The MeTA International Secretariat is tasked to help to support the implementation of MeTA in 7 pilot countries, through facilitating support for the evolution and effective functioning of the National Secretariats, National Multi-Stakeholder Group (NMSGs), and implementation of work plans. Following the establishment of country MeTA structures, the International MeTA Secretariat provides further support to the pilot countries including: Supporting countries to extract and collate data on medicine quality, availability and pricing along the supply chain; Supporting countries to undertake studies assessing the level of transparency and good governance in medicines regulation and procurement; Working with countries to produce country-specific MeTA reports, which would collate data and further analyse and contextualise issues related to medicine quality, availability and price, and to disseminate these reports through the media and public interest groups; as well as exploring policy options and support needed for implementation e.g. of report recommendations. Assist countries in using the data collated through MeTA on medicine policies and regulation as well as quality, availability and prices to try to promote relevant good practice and policy changes to improve access to medicines. HERA contracted staff are responsible for the provision of country specific support under META. Pilot countries are: Ghana, Uganda, Zambia, the Philippines, Jordan, Kyrgyzstan and Peru.
Year:	2008 - 2010

Assignment:	Medicines Transparency Alliance (MeTA)
Client:	DFID
Country:	The Philippines
Fields of expertise:	Access to Medicine Campaigns, Drug Pricing Studies, Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Essential Medicines Financing, Increasing Transparency In Public And Private Pharmaceutical Markets, National Medicines Policy Development, Public Private Partnership Interventions, Rational Use Surveys, Training and Human Resource Development
Description:	Narrative description of Project: MeTA is a new multi-stakeholder approach for increasing transparency around the selection, procurement, sale and distribution of medicines in Low Income Countries, thereby strengthening governance and encouraging responsible business practices. The MeTA goal is to ensure access to affordable essential drugs in developing countries (MDG 8, target 17). The initiative us being supported financially by DFID during its present Phase One. MeTA brings together, at both the international and national levels, a diverse group of people with an interest in the pharmaceutical sector (stakeholders) to find ways to improve information flows, and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. By doing so, MeTA will improve how decisions are made about medicines, improve the way they are purchased and supplied, encourage innovative and responsible business practices, and increase the voice of patients and consumers. Description of actual services provided by your staff within the assignment: The MeTA International Secretariat is tasked to help to support the implementation of MeTA in 7 pilot countries, through facilitating support for the evolution and effective functioning of the National Secretariats, National Multi-Stakeholder Group (NMSGs), and implementation of work plans. Following the establishment of country MeTA structures, the International MeTA Secretariat provides further support to the pilot countries including: Supporting countries to extract and collate data on medicine quality, availability and pricing along the supply chain; Supporting countries to undertake studies assessing the level of transparency and good governance in medicines regulation and procurement; Working with countries to produce country-specific MeTA reports, which would collate data and further analyse and contextualise issues related to medicine quality, availability and price, and to disseminate these reports through the media and public interest groups; as well as exploring policy options and support needed for implementation e.g. of report recommendations. Assist countries in using the data collated through MeTA on medicine policies and regulation as well as quality, availability and prices to try to promote relevant good practice and policy changes to improve access to medicines. HERA contracted staff are responsible for the provision of country specific support under META. Pilot countries are: Ghana, Uganda, Zambia, the Philippines, Jordan, Kyrgyzstan and Peru.
Year:	2008 - 2010

Assignment:	Medicines Transparency Alliance (MeTA)
Client:	DFID
Country:	Uganda
Fields of expertise:	Access to Medicine Campaigns, Drug Pricing Studies, Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Essential Medicines Financing, Increasing Transparency In Public And Private Pharmaceutical Markets, National Medicines Policy Development, Public Private Partnership Interventions, Rational Use Surveys, Training and Human Resource Development
Description:	Narrative description of Project: MeTA is a new multi-stakeholder approach for increasing transparency around the selection, procurement, sale and distribution of medicines in Low Income Countries, thereby strengthening governance and encouraging responsible business practices. The MeTA goal is to ensure access to affordable essential drugs in developing countries (MDG 8, target 17). The initiative us being supported financially by DFID during its present Phase One. MeTA brings together, at both the international and national levels, a diverse group of people with an interest in the pharmaceutical sector (stakeholders) to find ways to improve information flows, and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. By doing so, MeTA will improve how decisions are made about medicines, improve the way they are purchased and supplied, encourage innovative and responsible business practices, and increase the voice of patients and consumers. Description of actual services provided by your staff within the assignment: The MeTA International Secretariat is tasked to help to support the implementation of MeTA in 7 pilot countries, through facilitating support for the evolution and effective functioning of the National Secretariats, National Multi-Stakeholder Group (NMSGs), and implementation of work plans. Following the establishment of country MeTA structures, the International MeTA Secretariat provides further support to the pilot countries including: Supporting countries to extract and collate data on medicine quality, availability and pricing along the supply chain; Supporting countries to undertake studies assessing the level of transparency and good governance in medicines regulation and procurement; Working with countries to produce country-specific MeTA reports, which would collate data and further analyse and contextualise issues related to medicine quality, availability and price, and to disseminate these reports through the media and public interest groups; as well as exploring policy options and support needed for implementation e.g. of report recommendations. Assist countries in using the data collated through MeTA on medicine policies and regulation as well as quality, availability and prices to try to promote relevant good practice and policy changes to improve access to medicines. HERA contracted staff are responsible for the provision of country specific support under META. Pilot countries are: Ghana, Uganda, Zambia, the Philippines, Jordan, Kyrgyzstan and Peru.
Year:	2008 - 2010

Assignment:	Medicines Transparency Alliance (MeTA)
Client:	DFID
Country:	Zambia
Fields of expertise:	Access to Medicine Campaigns, Drug Pricing Studies, Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Essential Medicines Financing, Increasing Transparency In Public And Private Pharmaceutical Markets, National Medicines Policy Development, Public Private Partnership Interventions, Rational Use Surveys, Training and Human Resource Development
Description:	Narrative description of Project: MeTA is a new multi-stakeholder approach for increasing transparency around the selection, procurement, sale and distribution of medicines in Low Income Countries, thereby strengthening governance and encouraging responsible business practices. The MeTA goal is to ensure access to affordable essential drugs in developing countries (MDG 8, target 17). The initiative us being supported financially by DFID during its present Phase One. MeTA brings together, at both the international and national levels, a diverse group of people with an interest in the pharmaceutical sector (stakeholders) to find ways to improve information flows, and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. By doing so, MeTA will improve how decisions are made about medicines, improve the way they are purchased and supplied, encourage innovative and responsible business practices, and increase the voice of patients and consumers. Description of actual services provided by your staff within the assignment: The MeTA International Secretariat is tasked to help to support the implementation of MeTA in 7 pilot countries, through facilitating support for the evolution and effective functioning of the National Secretariats, National Multi-Stakeholder Group (NMSGs), and implementation of work plans. Following the establishment of country MeTA structures, the International MeTA Secretariat provides further support to the pilot countries including: Supporting countries to extract and collate data on medicine quality, availability and pricing along the supply chain; Supporting countries to undertake studies assessing the level of transparency and good governance in medicines regulation and procurement; Working with countries to produce country-specific MeTA reports, which would collate data and further analyse and contextualise issues related to medicine quality, availability and price, and to disseminate these reports through the media and public interest groups; as well as exploring policy options and support needed for implementation e.g. of report recommendations. Assist countries in using the data collated through MeTA on medicine policies and regulation as well as quality, availability and prices to try to promote relevant good practice and policy changes to improve access to medicines. HERA contracted staff are responsible for the provision of country specific support under META. Pilot countries are: Ghana, Uganda, Zambia, the Philippines, Jordan, Kyrgyzstan and Peru.
Year:	2008 - 2010